For at minimere den potentielle nephrotoksicitet, skal der gives oral probenecid og intravenøs præhydrering med natriumchlorid infusionsvæske ved hver VISTIDE- infusion.
To minimise potential nephrotoxicity, oral probenecid and intravenous saline prehydration must be administered with each VISTIDE infusion.